These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1134 related articles for article (PubMed ID: 9314636)

  • 21. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The homeostasis model in the San Antonio Heart Study.
    Haffner SM; Miettinen H; Stern MP
    Diabetes Care; 1997 Jul; 20(7):1087-92. PubMed ID: 9203442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia.
    Suzuki H; Fukushima M; Usami M; Ikeda M; Taniguchi A; Nakai Y; Matsuura T; Kuroe A; Yasuda K; Kurose T; Seino Y; Yamada Y
    Diabetes Care; 2003 Apr; 26(4):1211-5. PubMed ID: 12663599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
    Osei K; Gaillard T; Schuster DP
    Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of defective early phase insulin secretion on postload glucose intolerance in impaired fasting glucose.
    Sargin M; Ikiişik M; Sargin H; Orçun A; Kaya M; Gözü H; Dabak R; Bayramiçli OU; Yayla A
    Endocr J; 2005 Oct; 52(5):531-6. PubMed ID: 16284429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus.
    Kim DJ; Lee MS; Kim KW; Lee MK
    Metabolism; 2001 May; 50(5):590-3. PubMed ID: 11319722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
    Bacha F; Gungor N; Lee S; Arslanian SA
    Diabetes Care; 2009 Jan; 32(1):100-5. PubMed ID: 18835946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose Tolerance in Non-Diabetic Adult Subjects of an Urban West-African Population.
    Awede B; Lawani S; Adehan G; Akakpo J; Dossou E; Amoussou-Guenou M; Djrolo F
    Niger J Physiol Sci; 2017 Dec; 32(2):159-164. PubMed ID: 29485636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
    Tripathy D; Carlsson M; Almgren P; Isomaa B; Taskinen MR; Tuomi T; Groop LC
    Diabetes; 2000 Jun; 49(6):975-80. PubMed ID: 10866050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance.
    Ferrara CM; Goldberg AP
    Diabetes Care; 2001 Feb; 24(2):245-9. PubMed ID: 11213873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
    Salinitri FD; Pinelli NR; Martin ET; Jaber LA
    Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-hour post-load plasma glucose levels associated with decreased insulin sensitivity and secretion and early makers of cardiometabolic risk.
    Marcovecchio ML; Bagordo M; Marisi E; de Giorgis T; Chiavaroli V; Chiarelli F; Mohn A
    J Endocrinol Invest; 2017 Jul; 40(7):771-778. PubMed ID: 28255821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.